CRNX - Crinetics Pharmaceuticals, Inc. -  [ ]

Ticker Details
Crinetics Pharmaceuticals, Inc.
IPO Date: July 16, 2018
Sector: Healthcare
Industry: Biotech
Market Cap: $4.45B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.69 | 2.68%
Avg Daily Range (30 D): $1.18 | 2.37%
Avg Daily Range (90 D): $1.08 | 2.29%
Institutional Daily Volume
Avg Daily Volume: .38M
Avg Daily Volume (30 D): .81M
Avg Daily Volume (90 D): .89M
Trade Size
Avg Trade Size (Sh.): 62
Avg Trade Size (Sh.) (30 D): 48
Avg Trade Size (Sh.) (90 D): 54
Institutional Trades
Total Institutional Trades: 2,780
Avg Institutional Trade: $2.84M
Avg Institutional Trade (30 D): $3.74M
Avg Institutional Trade (90 D): $5.59M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $4.48M
Avg Closing Trade (30 D): $7.74M
Avg Closing Trade (90 D): $11.87M
Avg Closing Volume: 124.43K
 
News
Jan 26, 2026 @ 10:00 PM
Crinetics Pharmaceuticals to Report Fourth Quarter...
Source: Na
Jan 4, 2026 @ 9:00 PM
Crinetics Pharmaceuticals to Provide PALSONIFY Bus...
Source: Na
Dec 3, 2025 @ 1:00 PM
Crinetics Announces First Patient Dosed in Phase 1...
Source: Crinetics Pharmaceuticals
Nov 7, 2025 @ 9:16 PM
Why Crinetics Pharmaceuticals Stock Was Sliding on...
Source: Eric Volkman
Oct 10, 2025 @ 8:41 PM
Crinetics Pharmaceuticals Announces October 2025 I...
Source: Crinetics Pharmaceuticals
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $-1.38 $-1.23
Diluted EPS $-1.38 $-1.23
Revenue $.14M $1.03M
Gross Profit
Net Income / Loss $-130.09M $-115.64M
Operating Income / Loss $-142.59M $-129.11M
Cost of Revenue
Net Cash Flow $57.18M $-40.84M
PE Ratio